Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.55

-0.5

-0.46

-0.41

Details

Expected EPS

-0.514622

Actual EPS

-0.46

Surprise EPS

0.05

Surprise Percent

+10.61%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.46 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.